Wenkuan Chen

Papers

Total Citations

H-Index

About

Wenkuan Chen is a prominent surgical oncologist whose research centers on the surgical management of head and neck cancers, with a particular focus on oropharyngeal squamous cell carcinoma (OPSCC) and the application of transoral robotic surgery (TORS). Dr. Chen’s major contributions include pioneering the evaluation of TORS as a treatment modality for early-stage OPSCC, specifically analyzing its clinical safety and efficacy across both HPV-positive and HPV-negative patient populations in China. Their most cited work, a 2023 study on T1-T2 stage OPSCC treated with TORS, has garnered 12 citations and provides critical data on surgical outcomes, helping to establish TORS as a viable, minimally invasive alternative to traditional open surgery in Asian cohorts. By addressing the distinct biological behaviors of HPV-related and HPV-unrelated tumors, Dr. Chen has advanced personalized surgical strategies that improve functional preservation and reduce morbidity. Their research bridges a gap in global literature, offering region-specific evidence that informs clinical guidelines. With a growing citation impact, Dr. Chen is recognized for translating robotic surgical innovation into tangible patient benefits, making them a key figure in the evolution of head and neck oncology.